logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Renal Insufficiency

    FiltersReset Filters
    7 results

    • conray

      (iothalamate meglumine)
      Liebel-Flarsheim Company LLC
      Usage: Conray is indicated for excretory urography, angiography (cerebral, peripheral, venous), and various imaging techniques like computed tomography (CT) for detecting lesions in organs such as the liver and kidneys. It enhances diagnostic accuracy and visualization of lesions compared to unenhanced CT scans.

    • draximage dtpa

      (Kit for the preparation of Technetium Tc 99m Pentetate)
      Jubilant DraxImage Inc., dba Jubilant Radiopharma
      Usage: DRAXIMAGE® DTPA, after radiolabeling with Technetium Tc 99m, is indicated for brain imaging in adults, renal visualization and perfusion assessment in adults and pediatric patients, and lung ventilation imaging to evaluate pulmonary embolism in both adult and pediatric patients.

    • gadavist

      (gadobutrol)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Gadavist is indicated for MRI of the CNS, breast, magnetic resonance angiography (MRA), and cardiac MRI to detect abnormalities, assess malignant breast disease, evaluate artery disease, and assess myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease.

    • gadavist

      (gadobutrol)
      Bayer HealthCare Pharmaceuticals Inc.
      Usage: Gadavist is indicated for use in MRI of the CNS to visualize blood-brain barrier disruptions and abnormal vascularity, assess malignant breast disease in adults, evaluate supra-aortic or renal artery disease in MRA, and conduct cardiac MRI to assess myocardial perfusion and late gadolinium enhancement in patients with suspected CAD.

    • gadobutrol

      (Gadobutrol)
      Fresenius Kabi USA, LLC
      Usage: Gadobutrol injection is indicated for MRI of the central nervous system, breast, and magnetic resonance angiography (MRA) to detect abnormalities, assess malignancies, and evaluate arterial disease. It is also used in cardiac MRI to assess myocardial perfusion and late gadolinium enhancement in patients with suspected coronary artery disease.

    • gadobutrol

      (Gadobutrol)
      Fresenius Kabi USA, LLC
      Usage: Gadobutrol injection is indicated for use in MRI of the CNS to visualize blood-brain barrier disruptions, in MRI of the breast for malignant disease assessment, in MRA for vascular disease evaluation, and in cardiac MRI to assess myocardial perfusion and coronary artery disease in adults.

    • nephroscan

      (SUCCIMER)
      Theragnostics Inc
      Usage: NEPHROSCAN, after radiolabeling with technetium Tc 99m, is indicated for aiding in the scintigraphic evaluation of renal parenchymal disorders in both adult and pediatric patients, including term neonates.